Priming tissue-specific cellular immunity in a phase I trial of autologous dendritic cells for prostate cancer.
Burch, P A
Priming tissue-specific cellular immunity in a phase I trial of autologous dendritic cells for prostate cancer. [electronic resource] - Clinical cancer research : an official journal of the American Association for Cancer Research Jun 2000 - 2175-82 p. digital
Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
1078-0432
Acid Phosphatase--blood
Antigen-Presenting Cells--immunology
Cell Division--immunology
Dendritic Cells--immunology
Dose-Response Relationship, Drug
Granulocyte-Macrophage Colony-Stimulating Factor--therapeutic use
Humans
Immunotherapy--methods
Injections, Subcutaneous
Male
Prostate
Prostatic Neoplasms--immunology
Recombinant Fusion Proteins--therapeutic use
T-Lymphocytes--drug effects
Time Factors
Transplantation, Autologous
Priming tissue-specific cellular immunity in a phase I trial of autologous dendritic cells for prostate cancer. [electronic resource] - Clinical cancer research : an official journal of the American Association for Cancer Research Jun 2000 - 2175-82 p. digital
Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
1078-0432
Acid Phosphatase--blood
Antigen-Presenting Cells--immunology
Cell Division--immunology
Dendritic Cells--immunology
Dose-Response Relationship, Drug
Granulocyte-Macrophage Colony-Stimulating Factor--therapeutic use
Humans
Immunotherapy--methods
Injections, Subcutaneous
Male
Prostate
Prostatic Neoplasms--immunology
Recombinant Fusion Proteins--therapeutic use
T-Lymphocytes--drug effects
Time Factors
Transplantation, Autologous